Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CSBRthis companyChampions Oncology, Inc.	$4.87	-74.5×	20.93×	1.39×	183.22×	-13.9%	48.0%	-1.9%	-2.0%	-29.8%	-13.3%	-6.1%	1.15×	-0.8×	0×	0.96×	0.0%	3	-0.28	1	D+
ARTVArtiva Biotherapeutics, Inc.	$4.21	-1.25×	0.95×	0×	-1.1×	-84.3%	0.0%	0.0%	0.0%	-76.3%	-74.9%	-75.7%	0.1×	0.19×	0×	8.61×	0.0%	1	4.66	2	C+
ATRAAtara Biotherapeutics, Inc.	$8.18	6.93×	-5.89×	1.88×	7.02×	-5049.6%	82.4%	29.7%	27.1%	-84.9%	222.7%	-22.4%	-1.37×	1.15×	9.46×	0.82×	0.0%	1	-135.86	2	C
CNTBConnect Biopharma Holdings Limited	$0.75	-2.82×	3.74×	2,452.52×	-2.19×	-15.8%	100.0%	-90740.6%	-86687.5%	-132.2%	-135.7%	-32.9%	0.02×	0.69×	0×	3.74×	0.0%	2	-15.61	2	C+
IMAImageneBio Inc	$4.16	-0.72×	0.28×	46.85×	-0.28×	9.5%	-29.1%	-6056.4%	-5668.6%	-34.1%	-33.4%	-127.6%	0.08×	0.56×	0×	12.49×	0.0%	1	0.37	3	B
KLRSKalaris Therapeutics Inc	$2.49	-2.96×	1.63×	0×	-0.77×	212.6%	0.0%	0.0%	0.0%	-55.1%	-41.1%	-33.5%	0.02×	2.3×	-31.98×	12.23×	0.0%	0	-2.38	3	B
Peer median	—	-1.25×	0.95×	1.88×	-0.77×	-15.8%	0.0%	0.0%	0.0%	-76.3%	-41.1%	-33.5%	0.02×	0.69×	0×	8.61×	0.0%	1	-2.38	2	—